CA2557809A1 - Treatment of interstitial cystitis with vitamin d compounds - Google Patents

Treatment of interstitial cystitis with vitamin d compounds Download PDF

Info

Publication number
CA2557809A1
CA2557809A1 CA002557809A CA2557809A CA2557809A1 CA 2557809 A1 CA2557809 A1 CA 2557809A1 CA 002557809 A CA002557809 A CA 002557809A CA 2557809 A CA2557809 A CA 2557809A CA 2557809 A1 CA2557809 A1 CA 2557809A1
Authority
CA
Canada
Prior art keywords
compound
vitamin
methyl
mmol
hexane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002557809A
Other languages
English (en)
French (fr)
Inventor
Enrico Colli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bioxell SpA
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0404571A external-priority patent/GB0404571D0/en
Priority claimed from GB0404567A external-priority patent/GB0404567D0/en
Priority claimed from PCT/US2004/031532 external-priority patent/WO2005030223A1/en
Application filed by Individual filed Critical Individual
Publication of CA2557809A1 publication Critical patent/CA2557809A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002557809A 2004-03-01 2005-03-01 Treatment of interstitial cystitis with vitamin d compounds Abandoned CA2557809A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB0404567.0 2004-03-01
GB0404571.2 2004-03-01
GB0404571A GB0404571D0 (en) 2004-03-01 2004-03-01 Methods for treating interstitial cystitis and related compounds and compositions
GB0404567A GB0404567D0 (en) 2004-03-01 2004-03-01 Methods for treating bladder dysfunction and related compounds and compositions
PCT/US2004/031532 WO2005030223A1 (en) 2003-09-24 2004-09-24 Methods for treating bladder dysfunction
USPCT/US2004/031532 2004-09-24
PCT/EP2005/050902 WO2005082375A2 (en) 2004-03-01 2005-03-01 Treatment of interstitial cystitis with vitamin d compounds

Publications (1)

Publication Number Publication Date
CA2557809A1 true CA2557809A1 (en) 2005-09-09

Family

ID=34915952

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002557809A Abandoned CA2557809A1 (en) 2004-03-01 2005-03-01 Treatment of interstitial cystitis with vitamin d compounds

Country Status (7)

Country Link
US (1) US20080039434A1 (enExample)
EP (1) EP1737468A2 (enExample)
JP (1) JP2007525533A (enExample)
AU (1) AU2005216651A1 (enExample)
BR (1) BRPI0508333A (enExample)
CA (1) CA2557809A1 (enExample)
WO (1) WO2005082375A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2580962A1 (en) * 2004-09-24 2006-04-06 Bioxell S.P.A. 20-cycloalkyl,26,27-alkyl/haloalkyl vitamin d3 compounds and methods of use thereof
RU2423972C1 (ru) * 2009-12-16 2011-07-20 Государственное Образовательное Учреждение Высшего Профессионального Образования Амурская Государственная Медицинская Академия Росздрава Способ консервативного лечения гиперактивного мочевого пузыря у детей с учетом его суточной активности
WO2013053076A1 (en) 2011-10-10 2013-04-18 Zensun （Shanghai）Science & Technology Limited Compositions and methods for treating heart failure
US9149528B2 (en) * 2011-10-13 2015-10-06 Premier Dental Products Company Topical vitamin D oral supplement compositions
US9724542B2 (en) 2012-10-12 2017-08-08 Premier Dental Products Company Remineralizing and desensitizing compositions, treatments and methods of manufacture
EP2887945A4 (en) * 2012-10-12 2016-03-23 Premier Dental Products Co TOPICAL ORAL COMPOUND COMPOSITIONS OF VITAMIN D
US9877930B2 (en) 2012-10-12 2018-01-30 Premier Dental Products Company Topical ubiquinol oral supplement compositions with amorphous calcium phosphate
CN104758300A (zh) * 2014-01-02 2015-07-08 上海泽生科技开发有限公司 维生素d及其组合物的抗菌用途
RU2602954C1 (ru) * 2015-07-27 2016-11-20 Государственное бюджетное образовательное учреждение высшего профессионального образования "Ярославский государственный медицинский университет" Министерства здравоохранения Российской Федерации Средство для лечения хронических воспалительных заболеваний уретры и мочевого пузыря
WO2017147420A1 (en) * 2016-02-25 2017-08-31 The University Of Florida Research Foundation, Inc. Methods and compositions with vitamin d compounds for treatment of cystic fibrosis and respiratory disorders
JP7026686B2 (ja) 2016-11-23 2022-02-28 華為技術有限公司 １パッシブ光ネットワークシステム、光回線端末、および光ネットワークユニット

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3639596A (en) 1969-07-14 1972-02-01 Wisconsin Alumni Res Found Method of treating leg weakness in fowl with 25-hydroxycholecalciferol
US3739001A (en) 1971-10-22 1973-06-12 Wisconsin Alumni Res Found 25,26-dihydroxycholecalciferol
US3741996A (en) 1971-12-02 1973-06-26 Wisconsin Alumni Res Found 1{60 -hydroxycholecalciferol
US3715374A (en) 1972-05-05 1973-02-06 Wisconsin Alumni Res Found 24,25-dihydroxycholecalciferol
US3847955A (en) 1973-07-16 1974-11-12 Wisconsin Alumni Res Found 1,24,25-trihydroxycholecalciferol
JPS5126859A (en) 1974-08-22 1976-03-05 Teijin Ltd 24 * r * hidorokishikorekarushifuerooruno seizoho
JPS5126858A (en) 1974-08-22 1976-03-05 Teijin Ltd 24 * s * hidorokishikorekarushifuerooruno seizoho
JPS5271456A (en) 1975-12-12 1977-06-14 Chugai Pharmaceut Co Ltd Synthesis of 1alpha-hydroxysteroid derivatives
US4717721A (en) 1985-05-30 1988-01-05 Howard W. Bremer Sidechain homo-vitamin D compounds with preferential anti-cancer activity
US4927815A (en) 1988-04-29 1990-05-22 Wisconsin Alumni Research Foundation Compounds effective in inducing cell differentiation and process for preparing same
US4847012A (en) 1988-04-29 1989-07-11 Wisconsin Alumni Research Foundation Vitamin D related compounds and processes for their preparation
US4851401A (en) 1988-07-14 1989-07-25 Wisconsin Alumni Research Foundation Novel cyclopentano-vitamin D analogs
US5312328A (en) * 1991-01-11 1994-05-17 Baxter International Inc. Ultra-sound catheter for removing obstructions from tubular anatomical structures such as blood vessels
US20050090553A1 (en) * 1992-06-30 2005-04-28 Shapiro Howard K. Compositions and method for treatment of chronic inflammatory diseases
CA2096105A1 (en) 1992-10-07 1994-04-08 Enrico Giuseppe Baggiolini (Deceased) Vitamin d3 fluorinated analogs
US5428029A (en) * 1993-11-24 1995-06-27 Hoffmann-La Roche Inc. Vitamin D3 fluorinated analogs
EP1021401A1 (en) 1995-09-21 2000-07-26 Wisconsin Alumni Research Foundation Calcitriol derivatives and their uses
SG70009A1 (en) 1996-05-23 2000-01-25 Hoffmann La Roche Vitamin d3 analogs
US5939408A (en) * 1996-05-23 1999-08-17 Hoffman-La Roche Inc. Vitamin D3 analogs
KR100351490B1 (ko) 1997-04-28 2002-09-05 에프. 호프만-라 로슈 아게 비스 씨-20 측쇄를 갖는 비타민 디3 유사체
US6030962A (en) * 1997-04-28 2000-02-29 Synttex (U.S.A.) Inc. Vitamin D3 analogs with bis C-20 side chains
FR2763328B1 (fr) 1997-05-14 1999-07-02 Vetrotex France Sa Procede de production de fils de verre ensimes et produits resultants
US6017908A (en) * 1997-05-16 2000-01-25 Women And Infants Hospital 3-EPI vitamin D2 compounds and uses thereof
DE69832699T2 (de) 1997-05-16 2006-08-24 Woman & Infants Hospital Zyklische äther vitamin d3 verbindungen, 1alfa(oh) 3-epi-vitamin d3 verbindungen und deren verwendungen
WO2001040177A2 (en) 1999-12-02 2001-06-07 Women And Infants Hospital Esters of vitamin d3 and uses thereof
US20010034328A1 (en) * 2000-02-25 2001-10-25 Cartt Stephen Lahue Treatment of male chronic pelvic pain syndrome
WO2004098612A2 (en) 2003-05-07 2004-11-18 Ab Science Calcitriol analogs of uses thereof
US20070054887A1 (en) * 2003-09-24 2007-03-08 Bioxell S.P.A Methods for treating bladder dysfunction

Also Published As

Publication number Publication date
US20080039434A1 (en) 2008-02-14
BRPI0508333A (pt) 2007-07-17
WO2005082375A2 (en) 2005-09-09
JP2007525533A (ja) 2007-09-06
AU2005216651A1 (en) 2005-09-09
EP1737468A2 (en) 2007-01-03
WO2005082375A3 (en) 2005-10-13

Similar Documents

Publication Publication Date Title
US20080039434A1 (en) Treatment of Interstitial Cystitis with Vitamin D Compounds
JP2016006055A (ja) ビタミンｄ関連化合物の１−デオキシ類似体
BRPI0609666A2 (pt) uso de um composto de vitamina d, método para prevenir e /ou tratar endometriose, formulação farmacêutica, composto de vitamina d, e, kit
US20070054887A1 (en) Methods for treating bladder dysfunction
US20080280860A1 (en) Use of Vitamin D Compounds to Treat Endometriosis
ZA200606720B (en) Treatment of interstitial cystitis with vitamin D compounds
EP1178960B1 (en) Vitamin d analogues and their pharmaceutical use
US20080293647A1 (en) Combined Use Of Vitamin D Derivatives And Anti-Proliferative Agents For Treating Bladder Cancer
US20090298799A1 (en) Methods of Treating Osteoporosis and Secondary Hyperparathyroidism Using 20-Methyl, Gemini Vitamin D3 Compounds
WO2006035075A1 (en) Use of vitamin d compounds for the prevention or treatment of chronic prostatitis
ZA200602097B (en) Methods for treating bladder dysfunction
US20100093675A1 (en) Novel method
US20100009949A1 (en) Novel method
EP1589009B1 (en) Vitamin d3 lactone derivative

Legal Events

Date Code Title Description
FZDE Discontinued